Methotrexate is an anti-folate antitumor agent that inhibits the growth and multiplication of tumor cells by hindering their synthesis, mainly through the inhibition of dihydrofolate reductase (Rosh, 2022). This evidence concerns the gene DHFR and neoplasm.